|
|
Yale Comprehensive Cancer Center Support Grant
|
2P30CA016359-34
|
$2,531,005
|
$101,240
|
LYNCH, THOMAS
|
YALE UNIVERSITY
|
|
|
Yale Comprehensive Cancer Center Support Grant
|
3P30CA016359-34S1
|
$75,000
|
$3,000
|
Lynch, Thomas
|
YALE UNIVERSITY
|
|
|
Xenobiotic-Metabolizing Enzymes
|
ZIA BC 005562
|
$707,692
|
$176,923
|
Gonzalez, Frank
|
CCR (NCI)
|
|
|
Xenobiotic Receptors
|
ZIA BC 005708
|
$707,692
|
$141,538
|
Gonzalez, Frank
|
CCR (NCI)
|
|
|
WUMC Cancer and Leukemia Group B
|
5U10CA077440-16
|
$320,126
|
$83,233
|
BARTLETT, NANCY
|
WASHINGTON UNIVERSITY
|
|
|
Womens Health Initiative Cancer Survivor Cohort
|
3UM1CA173642-05S3
|
$175,562
|
$31,601
|
ANDERSON, GARNET
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
|
Women's Health Study: Continued Follow-up
|
5R01CA047988-22
|
$1,669,985
|
$333,997
|
BURING, JULIE
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
|
Women's Health Initiative Cancer Survivor Cohort
|
1UM1CA173642-01
|
$1,894,768
|
$341,058
|
ANDERSON, GARNET
|
FRED HUTCHINSON CAN RES CTR
|
|
|
Wnt Signaling in Colon Cancer
|
5R01CA108697-08
|
$269,326
|
$269,326
|
WATERMAN, MARIAN
|
UNIVERSITY OF CALIFORNIA-IRVINE
|
|
|
Wnt Signaling and Secreted Frizzled-Related Proteins
|
ZIA BC 010251
|
$318,862
|
$63,772
|
Rubin, Jeffrey
|
CCR (NCI)
|
|
|
Winship Cancer Institute Cancer Center Support Grant
|
3P30CA138292-05S2
|
$37,430
|
$749
|
Curran, Walter
|
EMORY UNIVERSITY
|
|
|
Winship Cancer Institute Cancer Center Support Grant
|
3P30CA138292-10S3
|
$234,000
|
$7,020
|
CURRAN, WALTER
|
EMORY UNIVERSITY
|
|
|
Winship Cancer Institute Cancer Center Support Grant
|
5P30CA138292-05
|
$1,396,397
|
$27,928
|
Curran, Walter
|
EMORY UNIVERSITY
|
|
|
WESTERN ONCOLOGY RESEARCH CONSORTIUM
|
5U10CA045377-27
|
$589,569
|
$58,957
|
Conlin, Alison
|
PROVIDENCE PORTLAND MEDICAL CENTER
|
|
|
Vitamin D Status, Genetic Variation in Vitamin D Signaling and Metabolism, and Ri
|
5R01CA140285-04
|
$285,146
|
$285,146
|
JACOBS, ELIZABETH
|
UNIVERSITY OF ARIZONA
|
|
|
Vitamin D Effect on Body Composition During Behavioral Weight Loss in Women
|
5R03CA162482-02
|
$82,720
|
$41,360
|
McTiernan, Anne
|
FRED HUTCHINSON CAN RES CTR
|
|
|
VITamin D and omegA-3 triaL (VITAL)
|
3U01CA138962-05S1
|
$154,236
|
$30,847
|
MANSON, JOANN
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
|
VITamin D and omegA-3 triaL (VITAL)
|
5U01CA138962-05
|
$1,849,208
|
$369,842
|
MANSON, JOANN
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
|
Virtual Fly-Over Colonoscopy System for Clinical Test-SBIR Phase 1
|
1R43CA179911-01
|
$148,821
|
$148,821
|
Elshazly, Salwa
|
KENTUCKY IMAGING TECHNOLOGIES, LLC
|
|
|
Virtual Colonoscopy and Colorectal Cancer Screening
|
5R01CA144835-04
|
$461,082
|
$461,082
|
SMITH, MAUREEN
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
|
Virginia Mason Community Clinical Oncology Program
|
5U10CA035192-29
|
$612,504
|
$61,250
|
Nichols, Craig
|
BENAROYA RESEARCH INST AT VIRGINIA MASON
|
|
|
Veterans Administration hospitalization database, Patient Treatment File, and Out
|
ZIA CP010126-00580
|
$52,897
|
$2,645
|
McGlynn, Katherine
|
DCEG (NCI)
|
|
|
VCU Minority-Based Community Clinical Oncology Program
|
3U10CA052784-23S1
|
$125,000
|
$16,250
|
Hackney, Mary
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
|
VCU Minority-Based Community Clinical Oncology Program
|
5U10CA052784-23
|
$431,709
|
$56,122
|
Hackney, Mary
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
|
VCU Massey Cancer Center Support Grant
|
3P30CA016059-37S3
|
$86,197
|
$3,448
|
GINDER, GORDON
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
|
Vascular Biology in Cancer
|
ZIA BC 011390
|
$1,345,130
|
$336,283
|
Lin, Pengnian Charles
|
CCR (NCI)
|
|
|
Vanderbilt Proteome Characterization Center
|
5U24CA159988-03
|
$2,613,578
|
$2,613,578
|
Liebler, Daniel
|
VANDERBILT UNIVERSITY MED CTR
|
|
|
Vanberbilt Biomarker Developmental Laboratory
|
5U01CA152647-04
|
$584,705
|
$292,353
|
Liebler, Daniel
|
VANDERBILT UNIVERSITY MED CTR
|
|
|
VALIDATION OF THE IPQ-R ADAPTED FOR COLORECTAL CANCER RISK
|
5R21CA164544-02
|
$186,458
|
$186,458
|
DESHPANDE, ANJALI
|
WASHINGTON UNIVERSITY
|
|
|
Validation of Metabolic Signature Epigenetic Biomarkers for Colon Cancer Risk
|
1R03CA180533-01
|
$77,500
|
$77,500
|
SAPIENZA, CARMEN
|
TEMPLE UNIV OF THE COMMONWEALTH
|
|
|
Validation of circulating tumor DNA assays for detection of metastatic melanoma
|
4UH3CA206124-03
|
$423,750
|
|
POLSKY, DAVID
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
|
|
Validation of a rapid point-of-care breath test for breast cancer
|
3R44CA203019-02S1
|
$224,700
|
|
PHILLIPS, MICHAEL
|
MENSSANA RESEARCH, INC.
|
|
|
Validation and Extension of the PREMM Model for Inherited Colorectal Cancer
|
2R01CA132829-05
|
$424,662
|
$424,662
|
SYNGAL, SAPNA
|
DANA-FARBER CANCER INST
|
|
|
Vaccines to promote Tc-1-based targeting of tumor stroma
|
5R01CA140375-04
|
$278,654
|
$139,327
|
Storkus, Walter
|
UNIVERSITY OF PITTSBURGH
|
|
|
Vaccine and radiation for the therapy of human cancers
|
ZIA BC 010975
|
$375,513
|
$37,551
|
Hodge, James
|
CCR (NCI)
|
|
|
Vaccine and Drug Combination Therapy for Human Cancers
|
ZIA BC 010661
|
$375,513
|
$75,103
|
Hodge, James
|
CCR (NCI)
|
|
|
UW Comprehensive CANCER CENTER SUPPORT
|
3P30CA014520-44S3
|
$75,711
|
$3,786
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
|
UW Comprehensive CANCER CENTER SUPPORT
|
3P30CA014520-44S4
|
$31,772
|
$1,589
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
|
UW Comprehensive Cancer Center Support
|
2P30CA014520-39
|
$4,133,528
|
$289,347
|
WILDING, GEORGE
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
|
UW Comprehensive Cancer Center Support
|
3P30CA014520-39S1
|
$37,429
|
$2,620
|
WILDING, GEORGE
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
|
UW Comprehensive Cancer Center Support
|
3P30CA014520-39S2
|
$122,414
|
$8,569
|
WILDING, GEORGE
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
|
UV/Vit D in radiologic technologists
|
ZIA CP010133-10416
|
$188,940
|
$28,341
|
Freedman, Daryl
|
DCEG (NCI)
|
|
|
Using vitamin D glucuronide pro-drugs to prevent/treat colon cancer
|
1R15CA173628-01
|
$435,848
|
$435,848
|
Goff, Jesse
|
IOWA STATE UNIVERSITY
|
|
|
Using mouse knockouts to unravel endothelial gene function
|
ZIA BC 010736
|
$215,271
|
$21,527
|
St. Croix, Brad
|
CCR (NCI)
|
|
|
Using FAP to Selectively Target Epithelial Cancers
|
5R01CA163930-02
|
$334,999
|
$167,500
|
BACHOVCHIN, WILLIAM
|
TUFTS UNIVERSITY BOSTON
|
|
|
Using Claims Data to Evaluate Radiation Therapy Utilization at the End of Life
|
5R21CA164449-02
|
$167,603
|
$33,521
|
Guadagnolo, Beverly
|
UT MD ANDERSON CANCER CTR
|
|
|
Use of Closely Related Inbred Strains to Identify Modifier Loci of Tumorigenesis
|
5R21CA169758-02
|
$158,449
|
$158,449
|
Siracusa, Linda
|
THOMAS JEFFERSON UNIVERSITY
|
|
|
USC Norris Comprehensive Cancer Center (CORE) Support
|
3P30CA014089-38S1
|
$12,500
|
$3,750
|
GRUBER, STEPHEN
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
|
USC Norris Comprehensive Cancer Center (CORE) Support
|
3P30CA014089-38S2
|
$12,459
|
$3,738
|
GRUBER, STEPHEN
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
|
USC Norris Comprehensive Cancer Center (CORE) Support
|
5P30CA014089-38
|
$5,870,229
|
$1,761,069
|
GRUBER, STEPHEN
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
Total relevant funding to Colon/Rectum for this search: $239,556,760
|
